Aramark
ARMK
$55.28
+0.44%
Aramark is a global foodservice and facilities management company founded in 1936 and headquartered in Philadelphia, operating primarily through its North American Food and Support Services segment, which serves schools, hospitals, corporate campuses, sports and entertainment venues, and correctional facilities, alongside a smaller International division. With roughly 278,000 employees and a market capitalization near $10-14 billion, Aramark is one of the largest outsourced services providers in North America, competing directly with Compass Group and Sodexo in a scale-driven, contract-based industry where retention rates and route density determine profitability. The current investor narrative centers on a post-2024 restructuring story: management has divested non-core assets, deleveraged the balance sheet, and refocused on higher-margin North American contracts, and the stock has responded with a 43.6% one-year gain and a 51.1% YTD advance that has outpaced the S&P 500 by roughly 39 percentage points. The debate now is whether the recent 9.3% revenue growth and margin expansion are durable enough to justify the re-rating, or whether the stock has run ahead of fundamentals after a sharp August earnings-driven gap higher and a subsequent fade.…
ARMK
Aramark
$55.28
Investment Opinion: Should I buy ARMK Today?
Rating: Buy. The synthesized recommendation is Buy, anchored by the strong analyst consensus (16 analysts, average target $68.59, 24.1% upside) and the company's successful post-restructuring execution, with revenue growth of 9.3% YoY and margin expansion. The core thesis is that ARMK is a deleveraging, margin-expanding services leader trading at a reasonable forward P/E of 19.65 with a PEG of 1.31, offering attractive upside despite thin margins. Supporting evidence includes: 1) Revenue growth of 9.3% YoY in Q3 2026, accelerating from prior quarters; 2) Gross margin expansion to 8.51% from 8.00%, and operating margin to 4.26% from 3.95%; 3) Positive free cash flow of $467.9M TTM, supporting debt reduction and dividends; 4) Implied upside of 24.1% to the average analyst target, with a high target of $75.50 (36.6% upside); 5) Forward P/E of 19.65 is below the trailing P/E of 31.45, indicating expected earnings growth. Risks include high leverage (D/E 1.82), thin net margin (1.76%), and recent price weakness (-4.0% 1M). The rating would upgrade to Strong Buy if the stock pulls back to the $47-50 range (analyst low target) or if margin expansion accelerates. It would downgrade to Hold if revenue growth decelerates below 5% or if the stock breaks below the 52-week low of $35.07. Valuation verdict: fairly valued to slightly undervalued relative to growth prospects, but not deeply discounted given the recent run-up.
Sign up to view all
ARMK 12-Month Price Forecast
The forward-looking view is bullish, supported by accelerating revenue growth, margin expansion, and a strong analyst consensus. The company's restructuring and deleveraging efforts have positioned it for sustainable growth, and the valuation remains reasonable on a forward basis. However, the recent price weakness and macro headwinds warrant medium confidence. An upgrade to high confidence would require a pullback to the $47-50 range or evidence of sustained margin expansion. A downgrade to neutral would occur if revenue growth falls below 5% or if the stock breaks below $50.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aramark's 12-month outlook, with a consensus price target around $68.59 and implied upside of +24.1% versus the current price.
Average Target
$68.59
0 analysts
Implied Upside
+24.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$47 - $76
Analyst target range
Bulls vs Bears: ARMK Investment Factors
The bull case for ARMK rests on a successful post-restructuring transformation, with accelerating revenue growth (9.3% YoY), margin expansion, and a strong analyst consensus (16 analysts, average target $68.59, 24% upside). The stock has delivered impressive relative performance (+43.6% 1Y vs. S&P 500's +15.5%), and the forward P/E of 19.65 with a PEG of 1.31 suggests reasonable valuation relative to growth. However, the bear case highlights thin margins (1.76% net), high leverage (D/E 1.82), and recent momentum deterioration (-4.0% 1M, underperforming by 5.3 percentage points). The most critical tension is whether the margin expansion and revenue growth are sustainable enough to justify the re-rating, especially given the stock's 51% YTD gain and the risk of multiple compression if growth decelerates. Currently, the bull evidence (analyst targets, growth trajectory, relative strength) appears stronger, but the margin of safety is thin given the recent pullback and macro uncertainty.
Bullish
- Analyst consensus strong buy with 24% upside: All 16 analysts rate ARMK a strong buy (recommendation mean 1.5) with an average target price of $68.59, implying 24.1% upside from the current $55.28. The high target of $75.50 suggests 36.6% potential appreciation, indicating robust institutional confidence in the turnaround story.
- Revenue growth accelerating and outpacing prior year: Q3 2026 revenue grew 9.33% YoY to $5.06B, up from $4.63B in Q3 2025. This acceleration is notable because it follows a period of slower growth, and the estimated FY2026 revenue of $28.28B represents continued momentum.
- Margin expansion driving earnings growth: Q3 2026 gross margin improved to 8.51% from 8.00% a year ago, and operating margin rose to 4.26% from 3.95%. Net income jumped 36% YoY to $97.7M, demonstrating operating leverage as revenue scales.
- Strong relative performance and momentum: ARMK has surged 43.6% over the past year and 51.1% YTD, outperforming the S&P 500 by 28.1 and 39.2 percentage points respectively. This relative strength reflects successful execution of the restructuring and deleveraging plan.
Bearish
- Thin margins leave little room for error: Net margin is only 1.76% and operating margin 4.28%, typical of low-margin foodservice but vulnerable to wage inflation and food cost volatility. A small margin compression could significantly impact earnings given the high fixed-cost base.
- High leverage constrains financial flexibility: Debt-to-equity is 1.82 and the current ratio is below 1.0 at 0.99, indicating potential liquidity tightness. Interest expense of $79.9M in Q3 2026 consumes a large portion of operating income ($215.6M), limiting reinvestment capacity.
- Recent price momentum has stalled: The stock is down 4.04% over the past month and 2.57% over three months, underperforming the S&P 500 by 5.26 percentage points in both periods. This recent weakness suggests the post-earnings gap higher may have exhausted near-term buying interest.
- Valuation appears stretched on trailing metrics: The trailing P/E of 31.45 and price-to-book of 3.27 are elevated for a low-margin services company. The EV/EBITDA of 12.31 is also above historical averages, implying the market has already priced in much of the recovery.
ARMK Technical Analysis
Beta
1.20
1.20x market volatility
Max Drawdown
-14.2%
Largest decline past year
52-Week Range
$35-$63
Price range past year
Annual Return
+43.6%
Cumulative gain past year
| Period | ARMK Return | S&P 500 |
|---|---|---|
| 1m | -4.0% | +0.2% |
| 3m | -2.6% | +2.9% |
| 6m | +22.2% | +8.4% |
| 1y | +43.6% | +14.9% |
| ytd | +51.1% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARMK Fundamental Analysis
Quarterly Revenue
$5.1B
2026-07
Revenue YoY Growth
+9.3%
YoY Comparison
Gross Margin
8.5%
Latest Quarter
Free Cash Flow
$467887000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARMK Overvalued?
PE
31.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 6x~49x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant given ARMK's thin margins and high leverage. Net margin is only 1.76%, and operating margin 4.28%, meaning a modest increase in food or labor costs could erase profitability. Debt-to-equity stands at 1.82, with interest expense of $79.9M in Q3 2026 consuming 37% of operating income ($215.6M). The current ratio below 1.0 (0.993) indicates potential liquidity constraints, and free cash flow of $467.9M TTM, while positive, must service this debt. Revenue concentration in North American Food and Support Services exposes the company to segment-specific downturns, and the low-margin contract structure limits pricing power. Market and competitive risks include valuation compression if growth slows. The trailing P/E of 31.45 and EV/EBITDA of 12.31 are above historical norms for a low-margin services firm, and the forward P/E of 19.65 leaves little room for disappointment. Competition from Compass Group and Sodexo is intense, and contract retention is critical. The beta of 1.195 indicates above-market volatility, and persistent inflation (as noted in recent news) could delay Fed rate cuts, pressuring discretionary spending and increasing refinancing costs. The stock's recent underperformance (-4.0% 1M, -5.3% relative to S&P) may signal waning momentum. Worst-case scenario: a combination of margin compression from wage inflation, loss of a major contract, and a broader market downturn could drive the stock toward its 52-week low of $35.07, representing a 36.6% decline from the current $55.28. The maximum drawdown over the past 180 days was -14.17%, but a more severe scenario could see a retest of the low, especially if earnings miss and analysts downgrade. Investors could lose over one-third of their investment in this adverse scenario.
FAQ
The key risks for ARMK, ranked by severity, are: 1) Financial risk from high leverage (D/E 1.82) and thin margins (net margin 1.76%), which could lead to liquidity issues if interest rates rise or cash flow declines; 2) Operational risk from contract concentration and retention, as losing a major client could significantly impact revenue; 3) Macro risk from persistent inflation and delayed Fed rate cuts, which could increase costs and reduce discretionary spending; 4) Valuation risk, as the stock's 51% YTD gain may have priced in much of the recovery, leaving it vulnerable to multiple compression if growth slows. Each risk is quantified: interest expense of $79.9M in Q3 2026, current ratio below 1.0, and a beta of 1.195 indicating above-market volatility.
The 12-month forecast for ARMK includes three scenarios: bull case (25% probability) with a target range of $68.59-$75.50, base case (50% probability) with a target range of $62.00-$68.59, and bear case (25% probability) with a target range of $35.07-$47.00. The base case is most likely, assuming revenue growth of 6-8% and stable margins, leading to a price around the analyst average target of $68.59. The key assumption is that the company continues to execute on its restructuring and margin expansion, with no major macro shocks. The bull case requires accelerated growth and multiple expansion, while the bear case assumes a recession or significant margin compression.
ARMK appears fairly valued to slightly undervalued relative to its growth prospects. The forward P/E of 19.65 is below the trailing P/E of 31.45, indicating expected earnings growth, and the PEG ratio of 1.31 is close to 1, suggesting the stock is reasonably priced for its growth. The EV/EBITDA of 12.31 is moderate for the services sector, and the price-to-sales of 0.56 is low, reflecting the thin margin business model. Compared to its own history, the stock has re-rated upward, but the analyst average target of $68.59 implies a 24% upside, indicating the market may still be undervaluing the earnings recovery. The valuation implies the market expects continued revenue growth and margin expansion, but not aggressively so.
ARMK presents a favorable risk/reward profile for investors with a medium risk tolerance. The stock trades at $55.28, offering 24.1% upside to the average analyst target of $68.59, with a strong buy consensus from 16 analysts. The forward P/E of 19.65 and PEG of 1.31 suggest reasonable valuation relative to expected earnings growth of 4.19 per share. However, the biggest downside risk is a retest of the 52-week low of $35.07, representing a 36.6% decline, driven by high leverage (D/E 1.82) and thin margins (1.76% net). Therefore, it is a good buy for growth-oriented investors who can tolerate volatility and believe in the sustainability of the margin expansion story, but conservative investors may prefer to wait for a pullback to the $47-50 range.
ARMK is more suitable for a medium-to-long-term investment horizon of at least 12-18 months, given its growth stage, moderate volatility (beta 1.195), and earnings visibility. The company pays a modest dividend (yield 1.08%), but the primary return driver is capital appreciation from the turnaround. Short-term trading is less advisable due to the stock's recent momentum stall and potential for volatility around earnings. A suggested minimum holding period is 12 months to allow the restructuring benefits to fully materialize and to ride out any near-term fluctuations. Long-term investors can benefit from the deleveraging story and margin expansion, but should monitor the risks outlined.